← Back to headlines
Maxim Upgrades Gilead Sciences (GILD) to ‘Buy’
Maxim has upgraded Gilead Sciences (GILD) to a ‘Buy’ rating. This reflects a positive outlook on the pharmaceutical company's stock.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
